Senior Director, Head of Safety Science (Pharmacovigilance)
Nuvalent, Inc.
About this role
Nuvalent is an early-stage biopharmaceutical company focused on creating selective cancer medicines. The Senior Director, Drug Safety and Pharmacovigilance will support development and implementation of a risk management system for investigational and marketed products and oversee risk management plan activities. The role includes responsibility for signal tracking, responses to health authority requests, and preparation of aggregate safety reports (e.g., DSURs, PADERs, PBRERs).
Skills
Qualifications
About Nuvalent, Inc.
nuvalent.comNuvalent is a clinical‑stage, Cambridge‑based oncology company that designs precisely targeted small‑molecule therapies using deep chemistry know‑how and structure‑based drug discovery. Its pipeline focuses on selective kinase inhibitors aimed at genetically defined cancers (ALK, ROS1, HER2 and other kinase-driven solid tumors) with the goal of overcoming resistance and improving patient outcomes. Lead programs include NVL‑520, NVL‑655 and NVL‑330, and the company highlights an approach centered on precision medicine, structure‑guided design, and translational development.
Recent company news
PR NewswireNuvalent Appoints Ron Squarer to Board of Directors
Dec 10, 2025
MarketBeatAmerican Century Companies Inc. Sells 11,767 Shares of Nuvalent, Inc. $NUVL
4 days ago
PR NewswireNuvalent Outlines Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2025 Financial Results
2 weeks ago
GuruFocusDecoding Nuvalent Inc (NUVL): A Strategic SWOT Insight
2 weeks ago
NasdaqRepare +30%, Nuvalent +9% Lead After-Hours Biotech Gains
Nov 16, 2025
About Nuvalent, Inc.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Nuvalent, Inc..
Salary
$275k – $300k
per year
More jobs at Nuvalent, Inc.
Similar Jobs
Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
IQVIA
Pharmacovigilance Manager, Aggregate & Trend Reports
American Regent
Pharmacovigilance Scientist (Safety Aggregate Report Specialist)
IQVIA
Sr. Director/Safety Scientist, Pharmacovigilance Operations
BridgeBio Pharma
Senior Manager, Pharmacovigilance
American Regent
Patient Safety & Pharmacovigilance (Science) Intern
Corcept Therapeutics